Apr 05, 2022 7:00am EDT Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference
Mar 30, 2022 4:05pm EDT Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC
Mar 03, 2022 7:00am EST Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
Feb 28, 2022 4:35pm EST Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
Jan 06, 2022 7:00am EST Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
Jan 05, 2022 4:30pm EST Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
Dec 27, 2021 7:00am EST Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China
Dec 27, 2021 7:00am EST Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer
Dec 13, 2021 7:00am EST Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021